Cedars-Sinai Medical Center opened the Cochran Brain Tumor Center in 2007 to shepherd basic research discoveries through patient trials and the government approval process. The Cochran Brain Tumor Center serves as a coordination point for the physicians who specialize in clinical trials, the data managers, and the clinical research nurses who interface with the Food and Drug Administration and institutional review boards to manage human studies. Led by Keith L. Black, MD, Chairman of the Department of Neurosurgery and Director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai, new discoveries and potential therapies undergo the extensive scrutiny, efficiently advancing basic research findings into early human studies.
Cedars-Sinai's research scientists, patient care teams and human trials research specialists are committed to accelerating the search for new treatments that will alleviate the suffering that brain tumors cause.
- To learn about the department's full range of patient support and information services, please click here.
- For information on research being conducted, please click here.
- For information on brain tumor clinical trials offered at Cedars-Sinai, please click here.
- For information on different types of brain tumors, please click here.
To make a donation to help support the leading-edge research center, please click here.
For an appointment, a second opinion or more information, please call 1-800-CEDARS-1 (1-800-233-2771) or email us at email@example.com.